CLSI H26A contains recommended performance goals for analytical accuracy and precision based on mathematical models for the following measurements: hemoglobin concentration, erythrocyte count, leukocyte count, platelet count, and mean corpuscular volume. (See related publications H07-A3, H15-A3, and H20-A in this section.)
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
